USD 3.29 billion
Drug Discovery Informatics Market Size, Share, and Growth Analysis
Drug Discovery Informatics Market By Function (Sequencing and Target Data Analysis, Docking), By Application (Drug Discovery, Drug Development), By Solution (Software, Services), By End User, By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2209 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
89
|Figures:
76
Format -
Drug Discovery Informatics Market Insights
Global Drug Discovery Informatics Market size was valued at USD 3.29 billion in 2023 and is poised to grow from USD 3.66 billion in 2024 to USD 8.62 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).
The expanding demand and support for rare illness and orphan drug development, together with biotechnology and pharmaceutical companies' increased research spending on informatics, are the main factors propelling the global drug discovery informatics market growth. The demand and rate of drug discovery informatics industry expansion are demonstrated by this growth in research expenditure. The process of discovering new drugs involves a great deal of information gathering. Drug discovery informatics comprises databases of different medications and compounds that are used for research by different pharmaceutical corporations. Database management and filtering are done with a variety of software. Informatics for drug discovery uses critical data, IT platforms, and other procedures to overcome obstacles.
Modern technology is used in this field for data processing, management, analysis, and storage. Improvements in high performance computing and online services, along with a greater emphasis on drug development through the use of informatics software, are the main factors propelling the drug discovery informatics industry. The increasing demand for new therapeutic agents as well as the increasing application of in silico modelling technologies will also stimulate the drug discovery informatics market growth. The high cost of informatics tools, however, might impede the growth of the market. Additionally, the growth of the biotechnology and biologics industries across developing countries will provide many lucrative business opportunities.
US Drug Discovery Informatics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Drug Discovery
Fastest Growth
Drug Development
Growth Rate
11.3% CAGR
Global Drug Discovery Informatics Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Drug Discovery Informatics Market Segments Analysis
Global Drug Discovery Informatics Market is segmented by Function, Application, Solution, End User and region. Based on Function, the market is segmented into Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation and Other functions. Based on Application, the market is segmented into Drug Discovery and Drug Development. Based on Solution, the market is segmented into Software and Services. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Drug Discovery Informatics Market Analysis by Application
As per categorization by application, the market is classified as drug discovery and drug development. Among these, the drug discovery earned the largest drug discovery informatics market share and continues to dominate the market. The global drug discovery informatics market outlook is witnessing significant dominance, driven by advancements in artificial intelligence, machine learning, and big data analytics. Such technologies make drug discovery applications more effective and precise by improving data management, molecular modeling and predictive analysis. The drug discovery applications are at the forefront of the market as they help in the rapid screening of potential drug candidates, reduce costs associated with development, better the rate of success, and most importantly ensure that therapeutic agents reach the patients more quickly.
Drug development applications are poised to be the fastest-growing segment in the global drug discovery informatics market due to their crucial role in optimizing the drug pipeline and enhancing efficiency. With the advent of development, pharmaceutical firms are under more pressure to shorten time to market and cost of development. Such applications enhance data integration and collaboration amongst research teams, making it possible to have ready insights. Furthermore, the emergence of personalized medications creates a need for complex informatics systems that will help in assessing huge amounts of biological information so that therapies are more targeted. Tied to these changes, drug development applications which would be analytics and simulation tools will be crucial enabling systems as regulatory requirements become more complex hence their quick uptake.
Drug Discovery Informatics Market Analysis by Function
Current innovations in sequencing and target data analysis are transforming the global drug discovery informatics market by enabling researchers to decipher complex biological systems more effectively. Technological breakthroughs in next generation sequencing (NGS) and in-bioinformatics allow for carrying out high data analysis for drug target and biomarker discovery. This function leads the markets owing to its ability to increase the accuracy of the drug discovery processes and predict responses of patients to various treatments. Moreover, AI and machine learning would enhance and quicken the data analysis, thus sequencing and analysis of target data becomes essential for the development of personalized medicine as well as for cheeses in the drug development period.
The molecular modeling function is set to become the fastest-growing segment in the global drug discovery informatics market due to its ability to simulate and visualize molecular interactions effectively. With the increasing need for precision medicine, molecular modeling has become a critical tool in understanding drug candidates' structure-activity relationships with a view of minimizing the classical-empirical trial and error associated with the experimental drug development process. The application of even more sophisticated computer engines of the sort of machine learning, artificial intelligence, and the like therefore improves the predictive capability of researchers enabling them to come up with more potent compounds. Again, the emergence of targeted therapies calls for more intricate molecular information, making molecular modeling imperative in speeding up the drug discovery and development timelines.
Global Drug Discovery Informatics Market By Application (%)
To get detailed analysis on other segments, Request For Free Sample Report
Drug Discovery Informatics Market Regional Insights
North America is dominating the global drug discovery informatics market primarily due to its robust pharmaceutical industry, significant investments in research and development, and a strong presence of leading biotech firms. The region is characterized by sophisticated technology and a high number of universities that encourage the processes associated with the discovery of new medicines. Moreover, governmental policies together with available funds for biopharmaceutical research propel the drug discovery informatics market expansion. The enhanced operational efficiencies due to the rising use of AI and big data analytics in drug development has also ensured that North America fully exploits the potential of advanced informatics solutions. All these reasons put the region in the best position in the drug discovery informatics skyline.
Europe is the fastest-growing region in the drug discovery informatics market, driven by its commitment to innovation in life sciences and a strong regulatory framework that encourages research and development. Many pharmaceutical and biotech firms present in the region are implementing more and more informatics solutions to speed up the process of drug discovery. Industry and academia join forces to promote progress in, among other regions, data analytics and bioinformatics which, coupled with the European Medicines Agency's efforts, stimulate the growth of the sector through improved drug approval processes. Europe's orientation towards such medicines as personalized medicine and precise therapies causes it to take the lead in the use of modern identification technologies.
Global Drug Discovery Informatics Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Drug Discovery Informatics Market Dynamics
Drug Discovery Informatics Market Drivers
Advancements in Data Informatics Technology
- The rapid advancements in technology, particularly in artificial intelligence and machine learning, are driving the global drug discovery informatics. These technologies take the capabilities of data analysis to another level. They allow researchers to handle overwhelming data volumes in a matter of minutes, and with great precision which, in turn, facilitates the search for molecular entities that can be turned into drugs and accelerates the entire process of drug discovery.
Increasing Demand for Personalized Medicine
- The increasing preference for personalized medicine is one of the most important factors propelling the drug discovery informatics market growth. Considering the advancements in healthcare towards custom made therapies, it becomes essential to have complex informatics systems to analyze genetic and clinical data. This in turn speeds up the drug discovery processes making treatment more effective for individual patients.
Drug Discovery Informatics Market Restraints
Data Privacy and Regulatory Challenges
- Concerns regarding data protection and the need to comply with the law present a formidable challenge to drug discovery informatics on a global scale. For example, the need to observe privacy laws such as GDPR makes it difficult to manage and even share information. All these make it difficult if not impossible to conduct research in a limit the degree to which companies embrace new informatics capabilities, thereby restricting growth.
Integration Complexity
- The difficulty associated with incorporating new drug discovery informatics systems into existing processes and structures can be a limiting factor in the global drug discovery informatics market growth. Most organizations do not succeed in accomplishing the full data interoperability they desire in order to operate efficiently without breaks in operation. This level of difficulty can discourage firms from implementing advanced levels of informatics solutions thus limiting the advantages they could provide.
Request Free Customization of this report to help us to meet your business objectives.
Drug Discovery Informatics Market Competitive Landscape
The competitive landscape of the drug discovery informatics industry is characterized by the presence of numerous players striving to innovate and enhance their offerings. The drug discovery informatics market is dominated by advanced informatics solutions and services supplied by major international players, such as Thermo Fisher Scientific, Roche, and PerkinElmer. Moreover, companies such as Charles River Laboratories and BioPharma Solutions are investing more in technologies and forming agreements to increase their share of the market, which is characterized by an increasing need for effective drug discovery techniques.
Top Players in Drug Discovery Informatics Market
- IBM (United States)
- Infosys Limited (India)
- Thermo Fisher Scientific (United States)
- PerkinElmer Inc. (United States)
- Schrodinger, Inc. (United States)
- Charles River Laboratories International, Inc. (United States)
- Certara, Inc. (United States)
- Accenture plc (Ireland)
- Agilent Technologies, Inc. (United States)
- Illumina, Inc. (United States)
- Dassault Systèmes SE (France)
- Collaborative Drug Discovery, Inc. (United States)
- Eurofins DiscoverX Products (United States)
- Jubilant Biosys Limited (India)
- Selvita S.A. (Poland)
- Novo Informatics Pvt. Ltd. (India)
- ChemAxon Ltd. (Hungary)
- Albany Molecular Research Inc. (United States)
- Boehringer Ingelheim GmbH (Germany)
- Oracle Corporation (United States)
Drug Discovery Informatics Market Recent Developments
- In October 2023, Thermo Fisher Scientific unveiled a new state-of-the-art platform based on predictive data analysis for drug discovery. This solution incorporates the latest advancements in artificial intelligence and machine learning to automate the process of handling data, thus enabling researchers to speed up the search for drug candidates and reduce the time taken to develop medicines.
- In September 2023, Roche unveiled its new cloud-based drug discovery informatics solution, aimed at enhancing collaboration among research teams. This platform allows for real-time data sharing and analysis, enabling researchers to access critical insights quickly. The initiative supports Roche’s commitment to innovation and efficiency in drug development processes.
- In November 2023, Agilent Technologies announced a new generation software system for drug discovery. This software includes improved molecular modeling and simulations tools enabling researchers to make more reliable predictions on the behavior of compounds. Through devising better methods for drug design, Agilent seeks to assist its customers in cutting back on developmental expenses and bringing forward new treatments onto the market.
Drug Discovery Informatics Key Market Trends
- Increasing Adoption of AI and Machine Learning: There is a noticeable rise in the use of AI and ML technologies in the drug discovery informatics industry. These tools improve the analysis of data, allow for faster identification of drug candidates, promote the use of predictive modeling, all of which lead to the stimulation of creativity and efficiency.
- Growing Focus on Personalized Medicine: The growing drug discovery informatics market trends show an increasing inclination towards personalized medicine, mainly due to the need for developing customized therapies. Adaptive informatics systems are employed to mine genetic and clinical data, enabling the creation of more effective and less harmful targeted therapies.
Drug Discovery Informatics Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global drug discovery informatics market is experiencing robust growth fueled by advancements in technology and an increasing focus on personalized medicine. The integration of AI and machine learning is revolutionizing data analysis, leading to more efficient drug candidate identification and development processes.
However, such constraints as privacy of data and the complexity of integration do not deter the market, as it still has vast opportunities for growth, especially in regions such as North America and Europe. With the ongoing adoption of informatics solutions by pharmaceutical companies, the efficient processes of drug discovery and development are expected to undergo revolutionary changes, with global positive implications for treated patients.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 3.29 billion |
| Market size value in 2032 | USD 8.62 billion |
| Growth Rate | 11.3% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Drug Discovery Informatics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Drug Discovery Informatics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Drug Discovery Informatics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Drug Discovery Informatics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Drug Discovery Informatics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Drug Discovery Informatics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
